IsoPlexis Overview

  • Founded
  • 2012
Founded
  • Status
  • Public
  • Employees
  • 342
Employees
  • Stock Symbol
  • ISO
Stock Symbol
  • Share Price
  • $10.37
  • (As of Friday Closing)

IsoPlexis General Information

Description

IsoPlexis Corp is a developer of a single-cell detection system designed to accelerate insights in the field of cancer.

Contact Information

Ownership Status
Publicly Held
Financing Status
Venture Capital-Backed
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Stock Exchange
NAS
Primary Office
  • 35 NorthEast Industrial Road
  • Suite 103
  • Branford, CT 06405
  • United States
+1 (475) 000-0000

IsoPlexis Timeline

2018201920202021
Financing RoundCaptured Employee CountEstimated Employee Growth
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

IsoPlexis Stock Performance

(As of Friday Closing)

Stock Price Previous Close 52 wk Range Market Cap Shares Average Volume EPS
$10.37 $10.75 $8.65 - $16.95 $419M 39M 289K -$1.85

IsoPlexis Financials Summary

In Thousands,
USD
TTM 30-Sep-2021 FY 2020 31-Dec-2020 FY 2019 31-Dec-2019
Revenue 15,120 10,387 7,505
EBITDA (59,827) (22,367) (13,127)
Net Income (64,362) (23,264) (13,626)
Total Assets 99,872 123,605 37,886
Total Debt 31,767 22,137 0
Public Fundamental Data provided by Morningstar, Inc. disclaimer

IsoPlexis Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore IsoPlexis‘s full profile, request access.

Request a free trial

IsoPlexis Cap Table

Stock # of Shares
Authorized
Par Value Dividend Rate (%) Original
Issue Price
Liquidation Liquidation
Pref. Multiple
Conversion
Price
% Owned

This information is available in the PitchBook Platform. To explore IsoPlexis‘s full profile, request access.

Request a free trial

IsoPlexis Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
IsoPlexis Corp is a developer of a single-cell detection system designed to accelerate insights in the field of cancer.
Discovery Tools (Healthcare)
Branford, CT
342 As of 2021
00000
0000 0000-00-00
00000000 00000

000000 0

mod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exerci
000000000 00000 (0000000000)
Cambridge, United Kingdom
00 As of 0000
000.00
0000000000 0 000.00

00000000

aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cil
0000000000000
Billerica, MA
00 As of 0000
00000
000 0000-00-00
000000&0 00000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

IsoPlexis Competitors (20)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Sphere Fluidics Venture Capital-Backed Cambridge, United Kingdom 00 000.00 0000000000 0 000.00
000000000 00000000 Formerly VC-backed Billerica, MA 00 00000 000000&0 00000
00000000 0000000 0 Formerly VC-backed Castel Maggiore, Italy 000 000.00 000000&0 000.00
000 000000000 0000 Formerly VC-backed Tucson, AZ 00 00000 000000000 - 00000
000000 Formerly VC-backed Freiburg, Germany 00 00.00 000000&0 00.00
You’re viewing 5 of 20 competitors. Get the full list »

IsoPlexis Patents

IsoPlexis Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
EP-3891504-A1 Systems, devices and methods for identification, selective ablation, and selection and collection of single cells Pending 04-Dec-2018 000000000000
EP-3545284-A1 Systems, devices and methods for cell capture and methods of manufacture thereof Pending 22-Nov-2016 00000000000
EP-3545284-A4 Systems, devices and methods for cell capture and methods of manufacture thereof Pending 22-Nov-2016 00000000000 0
US-20190376898-A1 Systems, devices and methods for cell capture and methods of manufacture thereof Pending 22-Nov-2016 00000000000
EP-3538891-A2 Compositions and methods for the simultaneous genomic, transcriptomic and proteomic analysis of single cells Pending 11-Nov-2016 G01N33/54386

IsoPlexis Executive Team (11)

Name Title Board Seat Contact Info
Sean Mackay Chief Executive Officer & Founder
John Strahley Chief Financial Officer, Finance
Jing Zhou Ph.D Chief Scientific Officer
Peter Siesel Executive
Timothy McConnell Ph.D Senior Scientific Fellow
You’re viewing 5 of 11 executive team members. Get the full list »

IsoPlexis Board Members (14)

Name Representing Role Since
Daniel Wagner Connecticut Innovations Board Member 000 0000
Gregory Ho JD Spring Mountain Capital Board Member 000 0000
James Heath Ph.D IsoPlexis Board Member 000 0000
Jason Myers Ph.D Self Board Member 000 0000
John Conley IsoPlexis Chairman & Board Member 000 0000
You’re viewing 5 of 14 board members. Get the full list »

IsoPlexis Signals

Growth Rate

0.80% Weekly
Growth
Weekly Growth 0.80%, 93rd %ile
-35.5%. 530%

Size Multiple

219x Median
Size Multiple 219x, 100th %ile
0.00x 0.95x. 413Kx

Key Data Points

Twitter Followers

5.5k

Similarweb Unique Visitors

15.0K

Majestic Referring Domains

314

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

IsoPlexis Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore IsoPlexis‘s full profile, request access.

Request a free trial